ArticleFrontiers in oncology2021

Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers.

Sameh Daher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.